levensten law firm logo

FDA Slaps New, Stricter Labeling on Testosterone Drugs Warning of Health Risks

The Food and Drug Administration’s tight scrutiny on testosterone-replacement drugs is getting even tighter. The regulator recently imposed stricter labeling requirements for low T products to warn of drug abuse dangers faced by people who use these products, including athletes and body builders. When men abuse testosterone medications, usually at higher doses than prescribed or taking together with another anabolic androgenic steroid (AAS), they can put themselves in serious danger. Abusing testosterone medications can impact a person’s mental health, physical health, and emotional health.  Anabolic androgenic steroids and other testosterone products are classified as controlled substances. There is a risk for abuse with these products by both adults and teenagers, who may use these products as a way of enhancing their strength and athletic performance.

This additional labeling follows the FDA’s 2015 warning that low T drugs could raise the cardiovascular factors leading to a heart attack, stroke or death. The latest labeling requirements raise even more questions about the safety of these medical products.

Testosterone treatment is a $2 billion a year industry involving prescriptions of gels, pills, and injections, according to Tech Times. These drugs treat men with low testosterone due to a certain medical conditions such as failure of the testicles to produce testosterone because of genetic problems, or damage to the testicles from infection or chemotherapy.

If you or a loved one has experienced a cardiac event such as a heart attack or stroke or a blood clot such as a DVT or PE after using a low T medication, you may be entitled to compensation. Contact the low T lawyers at the Levensten Law Firm at www.levenstenlawfirm.com, www.androgellawyers.com or 215-545-5600 for a free consultation.


Share the Post:

Related Posts


Your Warriors for Justice
Fight fearlessly. Win strategically.